Umpang, Anita D.

HRN: 23-08-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2024
CEFTRIAXONE 1G (VIAL)
01/09/2024
01/16/2024
IV
2gms
OD
UTI
Waiting Final Action 
01/11/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/11/2024
01/17/2024
IV
4.5g
Q8
Complicated UTI
Waiting Final Action 
01/12/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/12/2024
01/18/2024
IV
2.25g
Q6
Emphysematous Cystitis
Waiting Final Action 
01/12/2024
CLARITHROMYCIN 500MG (CAP)
01/12/2024
01/19/2024
PO
500 Mg
BID
Emphysematous Cystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: